基于机器学习的新型Janus激酶2抑制剂的药物重新定位,利用分子对接和分子动态模拟
Muhammad Yasir1, Jinyoung Park1, Eun-Taek Han2
1Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Journal of chemical information and modeling
|October 31, 2023
概括
机器学习有效地选了一个大型化学库,以寻找新的JAK2抑制剂. 计算和实验验证证证实了模型的模型.
科学领域:
- 计算化学和化学信息学
- 药物的发现和开发.
- 机器学习在药理学中的应用.
背景情况:
- 机器学习 (ML) 加快了药物发现,特别是用于识别现有药物的新疗法用途 (药物重新用途).
- 选大型化合物库对于识别新药候选药物至关重要,但传统方法耗时且昂贵.
研究的目的:
- 开发和应用一种机器学习模型,用于大型化学库的虚拟选,以识别新的Janus Kinase 2 (JAK2) 抑制剂.
- 用计算和实验方法验证ML模型的预测准确性.
主要方法:
- 一个随机森林回归模型被训练使用分子描述器从1911年已知的JAK2抑制剂与实验确定IC50值.
- 经过训练的模型预测了化学库中超过150万种化合物的IC50值.
- 有希望的候选人经历了分子对接,分子动力学模拟和对JAK2.2进行实验验证.
主要成果:
- 该ML模型成功地从一个大型化学库中预测了潜在的JAK2抑制剂.
- 计算分析,包括分子对接和动力学,支持预测的结合亲和关系.
- 实验验证证证实了精选化合物的JAK2抑制活性,显示了与参考药物托法西提尼布 (tofacitinib) 相似的结果.
结论:
- 机器学习模型为药物发现中的虚拟查提供了一种高效的方法.
- 这项研究证明了ML在识别新药候选者的有用性,特别是具有潜在治疗应用的JAK2抑制剂.
- 机器学习与计算和实验验证的整合增强了药物开发管道.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
734
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
734
01:16Protein-Drug Binding: Mechanism and Kinetics
534
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
534
01:26Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
01:22Protein-Drug Binding: Determination Methods
211
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
211
01:29Drug-Receptor Interactions
5.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K